Home
StockRanks™
Platform
Insights
Research & Discuss
Editorial & Community
Learn & Improve
Webinars & Masterclasses
Stockopedia Academy
Reviews
Pricing
Get started
Log in
Sectors
Healthcare
Biotechnology & Medical Research
Egetis Therapeutics AB (publ)
EGTX —
Egetis Therapeutics AB (publ)
News Story
SEK9.06
0.00
0.00%
Last trade -
00:00
Healthcare
Highly Speculative
Small Cap
Momentum Trap
Market Cap
SEK4.21bn
Enterprise Value
SEK3.90bn
Revenue
SEK62.40m
Quality
Value
Momentum
Stock
Rank
™
StockReport™
Accounts
Balance sheet
Income statement
Cashflow statement
Dividend summary
News
EGTX Dividends
StockReport™
Balance sheet
Income statement
Cashflow
News
EGTX Dividends
All News
Brief: Egetis Therapeutics Q1 Adjusted EPS SEK -0.2
Egetis Therapeutics AB (publ)
30/04/2025 06:00
Apr 30 (Reuters) - Egetis Therapeutics Q1 revenue SEK 12.7 million.
Recent news on Egetis Therapeutics AB (publ)
See all news
Egetis shares jump on US drug approval
29/09/2026 10:30
Brief: Egetis Therapeutics Reports Q2 Loss Of SEK 108.9 Million
21/08/2026 06:19
Sweden's Egetis Q2 revenue rises 23%
21/08/2026 06:11
Brief: Egetis Announces Grant Of Patent For MCT8 Deficiency Composition In U.S.
05/05/2026 07:19
Swedisg drugmaker Egetis's Q1 revenue rises 9% on Emcitate sales in Europe
29/04/2026 06:43